Skip to main content
. 2004 Feb;72(2):735–741. doi: 10.1128/IAI.72.2.735-741.2004

FIG. 4.

FIG. 4.

Rosette-inhibitory activity and total anti-EBA-175RII IgG antibody levels at enrollment in April 1998 in 83 individuals who were originally selected on the basis of presence or absence of susceptibility to clinical malaria but divided according to their parasitemia status at enrollment. Parasitemic, n = 43; nonparasitemic, n = 40.